申请人:Synta Pharmaceuticals Corp.
公开号:US20140187586A1
公开(公告)日:2014-07-03
The invention relates to compounds of structural formula (I):
or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein Y, L, X
1
, X
2
, Z, R
3
, R
4
, and n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.